Suppose there is a well-financed, one-year-old company in biotech industry that is concentrating on developing chemical-based compounds which are aimed at developing drugs to reduce the effects or onset of Alzheimer's Disease. What financial information (ratios or otherwise) would you think would be relevant or irrelevant from the viewpoint of possible investors in this company?